Startup Dossier
Yomi Pharma
Yomi Pharma is a French biotech company developing YomiPep, an innovative therapeutic peptide designed to combat resistant forms of EGFR-mutated lung cancer. The company focuses on addressing unmet needs in oncology through next-generation peptide-based treatments targeting drug-resistant tumors.
active
Typestartup
SectorBioTech
LocationLimoges
About
Yomi Pharma is a French biotech company developing YomiPep, an innovative therapeutic peptide designed to combat resistant forms of EGFR-mutated lung cancer. The company focuses on addressing unmet needs in oncology through next-generation peptide-based treatments targeting drug-resistant tumors.
Structural DNA
Legal Name
Yomi Pharma
SIREN
980941363
Founders & Team
Funding Lineage
Other
Capital Cell (Lead)
€1.2M
Oct 2025
Programs
i-Lab
2025Pharmacie & biotechnologies